All PlansPrior AuthMedium impact
Pharmacy Medical Policy Updates
Blue Cross Blue Shield of Kansas·KS · Neurology, Endocrinology, Rheumatology +2 more·Pharmacy
Effective date
Jul 1, 2023
We identified it
Jun 19, 2026
Summary
BCBS Kansas updated 15 pharmacy medical policies effective July 1, 2023, covering medications for multiple sclerosis, antifungals, osteoporosis treatments, migraine agents, and other specialized drugs. Two policies (Gabapentin ER and Lucemyra) have been retired and archived.
Action Required
By July 1, 2023: Billing team must review updated prior authorization requirements for affected medications including MS drugs, antifungals (Brexafemme/Cresemba/Noxafil/Vfend/Vivjoa), osteoporosis treatments, Rituximab, Tezspire, migraine agents, and CGM systems by checking specific medication lists at https://www.bcbsks.com/providers/precertification-prior-authorization. Stop processing prior auths for retired Gabapentin ER and Lucemyra policies.